Cryo Cell International (CCEL) Non-Current Deffered Revenue (2010 - 2026)
Cryo Cell International (CCEL) posted quarterly Non-Current Deffered Revenue of $53.3 million for Q2 2026, up 9.12% year-over-year from $48.8 million in Q2 2025, and up 2.24% quarter-over-quarter from $52.1 million in Q1 2026.
Cryo Cell International (CCEL) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has reported Non-Current Deffered Revenue for 17 consecutive years, with $53.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Deffered Revenue rose 9.12% year-over-year to $53.3 million; the TTM figure through May 2026 stood at $53.3 million (up 9.12% YoY), while the FY2025 annual figure was $51.0 million, up 9.49% from the prior year.
- Non-Current Deffered Revenue climbed to $53.3 million in Q2 2026 per CCEL's latest filing, from $52.1 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $53.3 million in Q2 2026 and bottomed at $32.2 million in Q1 2022.
- Historically, Non-Current Deffered Revenue has averaged $43.0 million across 5 years, with a median of $43.3 million in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Deffered Revenue increased 15.84% — and 2026, when it grew 9.12%.
- Cryo Cell International's Non-Current Deffered Revenue stood at $36.0 million in 2022, then increased by 14.41% to $41.2 million in 2023, then gained by 13.04% to $46.6 million in 2024, then increased by 9.49% to $51.0 million in 2025, then advanced by 4.5% to $53.3 million in 2026.
- Business Quant data shows CCEL's Non-Current Deffered Revenue at $53.3 million in Q2 2026, $52.1 million in Q1 2026, and $51.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | - |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | - |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 98.43 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | - |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | - |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 146.99 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | Cryo Cell International | 32.09 Mn | 28.93 Mn | 6.10 Mn | 53.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 53.27 Mn |
| Feb 28, 2026 | 52.10 Mn |
| Nov 30, 2025 | 50.97 Mn |
| Aug 31, 2025 | 49.84 Mn |
| May 31, 2025 | 48.82 Mn |
| Feb 28, 2025 | 47.73 Mn |
| Nov 30, 2024 | 46.56 Mn |
| Aug 31, 2024 | 45.20 Mn |
| May 31, 2024 | 43.92 Mn |
| Feb 29, 2024 | 42.60 Mn |
| Nov 30, 2023 | 41.19 Mn |
| Aug 31, 2023 | 39.97 Mn |
| May 31, 2023 | 38.65 Mn |
| Feb 28, 2023 | 37.25 Mn |
| Nov 30, 2022 | 36.00 Mn |
| Aug 31, 2022 | 34.67 Mn |
| May 31, 2022 | 33.37 Mn |
| Feb 28, 2022 | 32.15 Mn |
| Nov 30, 2021 | 31.27 Mn |
| Aug 31, 2021 | 30.40 Mn |